| Reconciliation of Segment Information to Total Consolidated Information |
Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2026 | (In millions) | | Developed Markets | | Greater China | | JANZ | | Emerging Markets | | Total Reportable Segments | Net sales | | $ | 2,193.7 | | | $ | 713.8 | | | $ | 296.1 | | | $ | 542.3 | | | $ | 3,745.9 | | Other revenues | | 9.3 | | | — | | | 0.1 | | | 1.5 | | | 10.9 | | Total revenues | | $ | 2,203.0 | | | $ | 713.8 | | | $ | 296.2 | | | $ | 543.8 | | | $ | 3,756.8 | | Less: | | | | | | | | | | | Cost of sales | | 1,036.2 | | | 77.4 | | | 180.3 | | | 237.1 | | | | Selling, general and administration | | 229.5 | | | 126.9 | | | 39.6 | | | 74.4 | | | | Segment profit | | $ | 937.3 | | | $ | 509.5 | | | $ | 76.3 | | | $ | 232.3 | | | $ | 1,755.4 | | | | | | | | | | | | | Reconciliation of segment profit: | | | | | | | | | | | Intangible asset amortization expense | | | | | | | | | | (571.9) | | | Intangible asset (including IPR&D) impairment charges | | | | (7.4) | | | | | | | | | | | | | Research and development | | | | | | | | | | (248.3) | | Acquired IPR&D | | | | | | | | | | 5.8 | | Litigation settlements & other contingencies, net | | | | | | | | | | (73.2) | | Transaction related and other special items | | | | | | | | | | (437.0) | | Corporate and other unallocated | | | | | | | | | | (417.1) | | | Earnings from operations | | | | | | | | | | $ | 6.3 | | | | | | | | | | | | | | | Six Months Ended June 30, 2026 | | (In millions) | | Developed Markets | | Greater China | | JANZ | | Emerging Markets | | Total Reportable Segments | Net sales | | $ | 4,214.5 | | | $ | 1,393.9 | | | $ | 569.5 | | | $ | 1,077.7 | | | $ | 7,255.6 | | Other revenues | | 14.5 | | | — | | | 0.2 | | | 3.5 | | | 18.2 | | Total revenues | | $ | 4,229.0 | | | $ | 1,393.9 | | | $ | 569.7 | | | $ | 1,081.2 | | | $ | 7,273.8 | | Less: | | | | | | | | | | | Cost of sales | | 2,048.6 | | | 148.3 | | | 354.7 | | | 456.7 | | | | Selling, general and administration | | 462.3 | | | 238.8 | | | 74.0 | | | 145.5 | | | | | Segment profit | | $ | 1,718.1 | | | $ | 1,006.8 | | | $ | 141.0 | | | $ | 479.0 | | | $ | 3,344.9 | | | | | | | | | | | | | Reconciliation of segment profit: | | | | | | | | | | | Intangible asset amortization expense | | | | | | | | | | (1,156.5) | | | Intangible asset (including IPR&D) impairment charges | | | | (7.4) | | | | | | | | | | | | | Research and development | | | | | | | | | | (496.9) | | Acquired IPR&D | | | | | | | | | | (0.2) | | Litigation settlements and other contingencies, net | | | | | | | | | | (126.7) | | Transaction related and other special items | | | | | | | | | | (819.4) | | Corporate and other unallocated | | | | | | | | | | (811.2) | | | Loss from operations | | | | | | | | | | $ | (73.4) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2025 | (In millions) | | Developed Markets | | Greater China | | JANZ | | Emerging Markets | | Total Reportable Segments | Net sales | | $ | 2,119.3 | | | $ | 588.9 | | | $ | 305.7 | | | $ | 555.1 | | | $ | 3,569.0 | | Other revenues | | 10.3 | | | — | | | 1.0 | | | 1.8 | | | 13.1 | | Total revenues | | $ | 2,129.6 | | | $ | 588.9 | | | $ | 306.7 | | | $ | 556.9 | | | $ | 3,582.1 | | Less: | | | | | | | | | | | Cost of sales | | 1,004.6 | | | 62.5 | | | 181.7 | | | 240.4 | | | | Selling, general and administration | | 249.5 | | | 124.6 | | | 41.3 | | | 78.4 | | | | Segment profit | | $ | 875.5 | | | $ | 401.8 | | | $ | 83.7 | | | $ | 238.1 | | | $ | 1,599.1 | | | | | | | | | | | | | Reconciliation of segment profit: | | | | | | | | | | | Intangible asset amortization expense | | | | | | | | | | (583.3) | | | Intangible asset (including IPR&D) impairment charges | | | | (2.2) | | | | | | | | | | | | | Research and development | | | | | | | | | | (218.8) | | Acquired IPR&D | | | | | | | | | | — | | Litigation settlements & other contingencies, net | | | | | | | | | | 47.6 | | Transaction related and other special items | | | | | | | | | | (212.8) | | Corporate and other unallocated | | | | | | | | | | (396.6) | | | Earnings from operations | | | | | | | | | | $ | 233.0 | | | | | | | | | | | | | | | Six Months Ended June 30, 2025 | | (In millions) | | Developed Markets | | Greater China | | JANZ | | Emerging Markets | | Total Reportable Segments | Net sales | | $ | 4,011.0 | | | $ | 1,144.4 | | | $ | 581.8 | | | $ | 1,075.0 | | | $ | 6,812.2 | | Other revenues | | 17.2 | | | — | | | 2.0 | | | 5.0 | | | 24.2 | | Total revenues | | $ | 4,028.2 | | | $ | 1,144.4 | | | $ | 583.8 | | | $ | 1,080.0 | | | $ | 6,836.4 | | Less: | | | | | | | | | | | Cost of sales | | 1,930.8 | | | 123.3 | | | 358.2 | | | 453.2 | | | | Selling, general and administration | | 483.8 | | | 234.6 | | | 79.7 | | | 152.7 | | | | | Segment profit | | $ | 1,613.6 | | | $ | 786.5 | | | $ | 145.9 | | | $ | 474.1 | | | $ | 3,020.1 | | | | | | | | | | | | | Reconciliation of segment profit: | | | | | | | | | | | Intangible asset amortization expense | | | | | | | | | | (1,154.5) | | | Intangible asset (including IPR&D) impairment charges | | | | (2.2) | | Impairment of goodwill | | | | | | | | | | (2,936.8) | | Research and development | | | | | | | | | | (440.8) | | Acquired IPR&D | | | | | | | | | | (10.0) | | Litigation settlements and other contingencies, net | | | | | | | | | | 121.1 | | Transaction related and other special items | | | | | | | | | | (469.3) | | Corporate and other unallocated | | | | | | | | | | (776.8) | | Loss from operations | | | | | | | | | | $ | (2,649.2) | |
|